semaglutide shortage over Federal judge upholds FDA's removal of Ozempic, Wegovy from drug list Maker of Ozempic and Wegovy

Advancements in pharmacotherapyparticularly glucagon-like peptide-1 (GLP-1) receptor agonists and dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) agents (henceforth referred to as GLP-1 and GLP-1/GIP medications)have emerged as a promising tool for weight management

Since coverage for weight loss medications is often subject to change, its best to review your plan regularly

doi: 10.2337/diacare.15.2.270 44 DayJWOttawayNPattersonJTGelfanovVSmileyDGiddaJet al

Science-Backed GLP-1 medications, like Mounjaro, Zepbound, and tirzepatide are FDA-approved for type 2 diabetes and have proven effective for weight loss